Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

The current standard of care treatment for severe hemophilia A and B (SHA and SHB) is the prophylactic intravenous replacement of coagulation factor VIII or IX (FVIII/FIX) to prevent spontaneous bleeding. Persons with hemophilia without prophylactic treatment receive therapy in case of bleeding, i.e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ay, Cihan, Perschy, Leonard, Rejtö, Judit, Kaider, Alexandra, Pabinger, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683481/
https://www.ncbi.nlm.nih.gov/pubmed/32918114
http://dx.doi.org/10.1007/s00277-020-04250-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683481/
https://www.ncbi.nlm.nih.gov/pubmed/32918114
http://dx.doi.org/10.1007/s00277-020-04250-9

Ejemplares similares